Log in to save to my catalogue

Specific insulin/IGF1 hybrid receptor activation assay reveals IGF1 as a more potent ligand than ins...

Specific insulin/IGF1 hybrid receptor activation assay reveals IGF1 as a more potent ligand than ins...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4300458

Specific insulin/IGF1 hybrid receptor activation assay reveals IGF1 as a more potent ligand than insulin

About this item

Full title

Specific insulin/IGF1 hybrid receptor activation assay reveals IGF1 as a more potent ligand than insulin

Author / Creator

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2015-01, Vol.5 (1), p.7911-7911, Article 7911

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

This novel method enables specific measurement of the activation of hybrid receptors formed between the Insulin Receptor (IR) and the Insulin-like Growth Factor 1 Receptor (IGF1R). These hybrid receptors are present in tissues and cell lines expressing both IR and IGF1R. It is therefore challenging to separate the homodimer and hybrid receptor acti...

Alternative Titles

Full title

Specific insulin/IGF1 hybrid receptor activation assay reveals IGF1 as a more potent ligand than insulin

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4300458

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4300458

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/srep07911

How to access this item